AUPH EQUITY ALERT: ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Encourages Aurinia Pharmaceuticals Inc. Investors with Losses Exceeding $100K to Inquire About Securities Class Action Investigation - AUPH Pharmaceutical Investing
FDA Approves LYNPARZA® as Adjuvant Treatment for Patients With Germline BRCA-Mutated , HER2-Negative High-Risk Early Breast Cancer Who Have Been Treated With Neoadjuvant or Adjuvant Chemotherapy Life Science Investing
Bristol Myers Squibb to Report Results for First Quarter 2022 on April 29, 2022 Pharmaceutical Investing
AbbVie and Gedeon Richter Announce Collaboration in Neuropsychiatric Diseases Pharmaceutical Investing
Albert Labs Closes $4.7m Private Placement; Begins Trading on the Canadian Securities Exchange Pharmaceutical Investing
AbbVie Announces Positive Phase 3 Atogepant ) Data for the Preventive Treatment of Chronic Migraine Pharmaceutical Investing
How Investing in Mental Health is an Investment in Combating Opioid Addiction Pharmaceutical Investing
Talc-Cancer Lawsuits Play Critical Role in Exposing Johnson & Johnson's Unethical Experiments on Prisoners Pharmaceutical Investing
Numinus Adds Ayahuasca & San Pedro to Federal License for Psychedelic Research Pharmaceutical Investing
Bristol Myers Squibb to Participate in Upcoming Investor Conferences on March 16 Pharmaceutical Investing
Pfizer Initiates Phase 2/3 Study of Novel COVID-19 Oral Treatment in Pediatric Participants Life Science Investing
